United States · FDA National Drug Code directory
TIZANIDINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84386-024_7ce17c02-7f1f-4d52-8b6f-52e385e12239
- Product NDC
- 84386-024
- Form
- TABLET
- Composition / generic term
- TIZANIDINE
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260901
- Source listing expiry
- 20271231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 150 TABLET in 1 BOTTLE (84386-024-77) · 84386-024-77
- 1000 TABLET in 1 BOTTLE (84386-024-99) · 84386-024-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →